Stay updated with breaking news from Essen Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Artificial Intelligence in Healthcare: Intellectual Property Landscape" report has been added to ResearchAndMarkets.com's offering. This...
/PRNewswire/ -- The "Artificial Intelligence in Healthcare: Intellectual Property Landscape" report has been added to ResearchAndMarkets.com's offering. This...
Founder-Led Connectivity Testing Leader To Grow Through a Variety of Operational Initiatives and Strategic Acquisitions RYE, N.Y. and SANTA CLARA, Calif., May 12, 2021 /PRNewswire/ -- SFW
Science for just $15 USD. Short circuiting solid tumors Two major hurdles in chimeric antigen receptor (CAR) T cell therapy for solid tumors are ensuring specificity to tumor cells without affecting healthy cells and avoiding tumor escape due to antigen loss. To address these challenges, Hyrenius-Wittsten et al. and Choe et al. developed synthetic Notch (synNotch)–CAR T cells targeting solid tumor antigens and used them to treat mouse models of mesothelioma, ovarian cancer, and glioblastoma. In both studies, the authors demonstrated that synNotch-CAR T cells were better at controlling tum...
Press release content from PR Newswire. The AP news staff was not involved in its creation. SFW Capital Completes Strategic Recapitalization of Caron Products and Services January 13, 2021 GMT RYE, N.Y., Jan. 13, 2021 /PRNewswire/ -- SFW Capital Partners (“SFW”), a specialized private equity firm that invests in leading providers of instrumentation, laboratory products, software/information and related solutions, today announced that it has completed a recapitalization of Caron Products and Services, Inc. (“Caron”). Caron is a leading provider of laboratory equipment used in small and...